Pay in 4 interest-free payments of $5.21 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
This type of clear pricing can help patients feel more comfortable starting a conversation about medical weight loss without feeling pressured into a long-term commitment
Kious BM, Kondo DG, Renshaw PF
Clinical Decision Summary Patients and clinicians weighing Mounjaro versus retatrutide face a choice between an approved, commercially accessible drug with 72-week phase 3 data and an investigational agent with 48-week phase 2 data that shows numerically superior weight loss but substantially higher GI discontinuation rates
However, concerns have persisted regarding their potential association with pancreatitis
US$ 27.20
US$ 21.85
US$ 22.34
